LeaderShares AlphaFactor US Core Equity ETF (LSAF)
Live price chart, market sentiment, and community perspectives for LeaderShares AlphaFactor US Core Equity ETF (AMEX: LSAF).
Live price chart, market sentiment, and community perspectives for LeaderShares AlphaFactor US Core Equity ETF (AMEX: LSAF).
On our desk, we are monitoring LSAF's recent activity where short interest popped by 59.6% in July. Even though that surge brought the absolute short position to only 822 shares, the minuscule average trading volume of roughly 4,300 to 4,900 shares means the days-to-cover ratio sits tight at 0.2. Market participants need to recognize that low float liquidity makes this a name where execution via limit orders is an absolute operational necessity rather than a suggestion.
Reviewing the quantitative metrics on LSAF, the fund tracks the AlphaFactor U.S. Core Equity Index using a rules-based multi-factor model covering buybacks, free cash flow, and debt-to-asset levels. While it showcases a conservative 5-year beta of 0.95 and a five-year downside capture ratio of 103 versus a category average of 108, the 0.75% expense ratio and historical vulnerability to deep drawdowns present a challenging hurdle for risk-adjusted alpha.
When evaluating LSAF for broader portfolio integration, we note that its P/E ratio sits at an attractive 15.10 with 101 holdings. However, analysts should weigh these fundamentals against the fund's Morningstar Medalist rating context and Redwood Investment Management's execution framework. The small asset scale around $106M–$125M dictates that institutional rebalancing can easily introduce localized price slippage if execution parameters aren't tightly managed.
Looking at the technical landscape through our quantitative lens, LSAF's recent price near $55.62 occupies a fascinating zone. With algorithmic screens showing that no resistance levels remain above the current price point, the structural upside potential looks technically unencumbered. That said, near-term neutral sentiment points to a potential stall as the market digests mid- and long-term strength against broader macro backdrops.
When digging into LSAF's underlying rules-based methodology, the selection universe starts with the largest 1,000 U.S. public companies before filtering via data-driven screening. In our assessment, while the qualitative design attempts to blend value metrics with growth without sacrificing stability, the peer comparison highlights persistent headwinds regarding high portfolio turnover and elevated fees that erode net compounding returns over multi-year horizons.
Explore plasma cleansing, somatic organ swaps, and BCI.